{"id":1667,"date":"2020-04-01T17:38:00","date_gmt":"2020-04-01T09:38:00","guid":{"rendered":"http:\/\/www.bioactivescreeninglibrary.com\/?p=1667"},"modified":"2022-01-07T10:56:56","modified_gmt":"2022-01-07T02:56:56","slug":"signals-integrin-receptors-regulate-multiple-cell-bmp2-activation-smads","status":"publish","type":"post","link":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2020\/04\/01\/signals-integrin-receptors-regulate-multiple-cell-bmp2-activation-smads\/","title":{"rendered":"Signals from integrin receptors regulate multiple cell on BMP2 activation of Smads"},"content":{"rendered":"

The ultimate consequence of BMP-2 signaling is the activation of gene transcription, which promotes osteoblast differentiation and bone formation. Jeong et al. reported that GS-5734<\/a> COMP-Ang1 enhanced the BMP-2dependent transcriptional activity of the OG2 or 6xOSE promoters, indicating that the Ang1\/Tie2 system might be involved in BMP-2-induced osteogenesis and modulation of BMP-2 target gene expression. They suggested that the effects of COMP-Ang1, MAPK, and PI3kinase\/Akt signaling pathways may be a mechanism for the observed synergy. Tie2 phosphorylation followed by Ang1 binding to the receptor results in activation of PI3-kinase\/Akt signaling pathway. The present study showed that COMP-Ang1 stimulated BMP-2-mediated induction of Akt phosphorylation as well as Smads and p38 MAPK phosphorylation, indicating that the synergy of COMP-Ang1 and BMP2 on osteoblast differentiation may be related to at least partial overlap of signaling pathways in osteoblasts. The positive effect of BMP-2 on osteoblast cells is well known; however, high failure rates and complications were reported when rhBMP-2 was used in treatment. In addition, TGF-b is responsible for the therapeutic resistance of BMP-2, as it causes BMP signaling interference. Transgenic mice lacking functional TGF-b signaling in osteoblasts or mice treated with the TGF-b type I receptor kinase inhibitor SD208 have increased trabecular bone mass with tougher femurs and stiffer and stronger vertebral bodies. These data suggest that continuous exposure to active TGF-b might harm bone physiology, as can be seen in patients suffering from chronic inflammation, whose active TGF-b1 serum levels are often constantly elevated. In this study, serum TGF-b1 levels were increased 4-fold two weeks after surgery in all four animal groups. One possible mechanism by which TGF-b1 may exert its inhibitory effect on osteoblast differentiation is through interference with BMP signaling. In this study, COMP-Ang1 decreased phosphorylation of Smad2\/3, a downstream protein of TGF-b1 pathways. Therefore, these results suggest that COMP-Ang1 inhibits the TGF-b1 signaling pathway in addition to enhancing the BMP-2 signaling pathway. According to previous studies, the Tie2 receptor, a target of COMP-Ang1, is expressed in quiescent hematopoietic stem cells of the bone marrow. Our study showed that the Tie2 receptor is expressed in C3H10T1\/2 cells. Based on these findings, we hypothesized that COMP-Ang1 also plays a direct role in osteoblast differentiation through the Ang1-Tie2 pathway. Meanwhile, COMP-Ang1 interacts with integrins and promotes endothelial cell survival. Integrins work as extracellular matrix receptors that transduce signals from the environment into the cell interior.<\/p>\n","protected":false},"excerpt":{"rendered":"

The ultimate consequence of BMP-2 signaling is the activation of gene transcription, which promotes osteoblast differentiation and bone formation. Jeong et al. reported that GS-5734 COMP-Ang1 enhanced the BMP-2dependent transcriptional activity of the OG2 or 6xOSE promoters, indicating that the Ang1\/Tie2 system might be involved in BMP-2-induced osteogenesis and modulation of BMP-2 target gene expression. … Continue reading “Signals from integrin receptors regulate multiple cell on BMP2 activation of Smads”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1667"}],"collection":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1667"}],"version-history":[{"count":1,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1667\/revisions"}],"predecessor-version":[{"id":1668,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1667\/revisions\/1668"}],"wp:attachment":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1667"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}